Attachment J11 - COVID19 Visitor Questionnaire at JL.pdf

PDF 39 KB Posted

Attached to
Amendment 1 -Construction of Production Water Well at NCTR Federal contract opportunity
Solicitation number
FDA-SOL-1224382
Issued by
Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services

About this file

This document contains a visitor questionnaire and risk assessment for Jefferson Labs during the COVID-19 pandemic. The questionnaire requires visitors to provide their name, the name of the sponsoring JL staff and division, approving official, and travel history for the past three weeks. It asks whether the visitor has been in contact with or within six feet of someone diagnosed or suspected of having COVID-19 or been quarantined, and whether they have a fever, cough or shortness of breath. The JL staff must complete and return the questionnaire within 48 hours prior to the visitor's arrival and email it to the specified FDA addresses.

The related federal contract opportunity is a solicitation from the FDA for the installation of a new water well at the National Center for Toxicological Research in Jefferson, Arkansas. The solicitation number is FDA-SOL-1224382 and seeks a contractor to construct a new production water well to supply the NCTR/Arkansas Regional Laboratory's water needs.

View the file

Other files for this federal contract opportunity

Other files attached to Amendment 1 -Construction of Production Water Well at NCTR, newest first.
File Type Posted
Amendment 1_rdw.pdf PDF
FDA_SOL_75F40120R00024 .pdf PDF
Attachment J6 - Past Performance Evaluation Questionnaire.pdf PDF
Attachment J10 - Statement of Work.pdf PDF
Attachment J4 - Wage Detemination AR.pdf PDF
Attachment J8 - FDA Form 3398.pdf PDF
Attachment J9 - Certification of Current Arkansas State Contractors License.pdf PDF
Attachment J2 - Drawings.pdf PDF
Attachment J7 - FORM FDA 3391.pdf PDF
Attachment J5 - Sample Client Letter.pdf PDF
Attachment J1 - Project Manual.pdf PDF
Attachment J3 - Cost Proposal Bid Schedule.pdf PDF
Show all 12

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Clinic Risk Assessment Questionnaire for Jefferson Labs (JL) Visitors Prior to their Arrival on Campus (Updated 30 June 2020)

(One per visitor)

Effective June 1, 2020 and until further notice, EVERYONE entering the campus is required to wear a face covering. No exceptions! Thank you for your cooperation.

Visitor’s Name/Company:

Name of JL staff (sponsor/escort) and Division/Contractor:

Name of the Approving Official:

1. Has the JL staff member received approval from the supervisor or Division Director for the visitor? YES or NO

2. The JL staff member must provide a statement stating why the visitor is essential:

Statement:

3. The visitor must provide his/her travel history for the past 3-weeks; within and/or outside of the United States

4. Has the visitor been in contact with, or within 6 feet of a person diagnosed with or suspected of having the coronavirus disease, or quarantined for coronavirus disease?

YES or NO

5. Does the visitor have fever (greater than 100.4 degrees Fahrenheit), cough or shortness of breath? YES OR NO

If yes, please list your symptoms:

It is the responsibility of the JL staff to have your visitor complete and return this questionnaire within 48 hours prior to their arrival on center and email to: NCTROHU@fda.hhs.gov and Elvin.Sprankle@fda.hhs.gov

Please notify the OHU if the answers to the questions change prior to entry to center at 870-543-7333 mailto:NCTROHU@fda.hhs.gov mailto:NCTROHU@fda.hhs.gov mailto:Elvin.Sprankle@fda.hhs.gov mailto:Elvin.Sprankle@fda.hhs.gov

File details come from the government source that posted it. Updated .